These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2845781)

  • 1. Clinical experience with labetalol and enalapril in combination in patients with severe essential and renovascular hypertension.
    White WB; Aydelotte ME
    Am J Med Sci; 1988 Sep; 296(3):187-91. PubMed ID: 2845781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of labetalol versus enalapril as monotherapy in elderly patients with hypertension: results of 24-hour ambulatory blood pressure monitoring.
    Applegate WB; Borhani N; DeQuattro V; Kaihlanen PM; Oishi S; Due DL; Sirgo MA
    Am J Med; 1991 Feb; 90(2):198-205. PubMed ID: 1996588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW; Laugerotte A; Wright JM
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enalapril versus triple-drug therapy in the treatment of renovascular hypertension.
    Reams GP; Bauer JH
    Drugs; 1985; 30 Suppl 1():59-69. PubMed ID: 2994988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renovascular hypertension: treatment with the oral angiotensin-converting enzyme inhibitor enalapril.
    Jackson B; Murphy BF; Johnston CI; Kincaid-Smith P; Whitworth JA
    Am J Nephrol; 1986; 6(3):182-6. PubMed ID: 3017107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of dilevalol and enalapril administered once daily for mild hypertension.
    Rodriguez-Saavedra M; Zannad FM; Guerrero-Sierra J; Sack DW; Renaud H; Guiducci U; Edwards LD
    Am J Cardiol; 1989 Jun; 63(19):50I-53I. PubMed ID: 2543201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Step II treatment with labetalol for essential hypertension.
    Bloomfield SS; Lucas CP; Gantt CL; Poland MP; Medakovic M
    Am J Med; 1983 Oct; 75(4A):81-6. PubMed ID: 6356902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of enalapril plus hydrochlorothiazide with standard triple therapy in renovascular hypertension.
    Franklin SS; Smith RD
    Nephron; 1986; 44 Suppl 1():73-82. PubMed ID: 3018602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN
    Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enalapril in the management of hypertension associated with renal artery stenosis.
    Canzanello VJ; Madaio MP; Madias NE
    J Clin Pharmacol; 1987 Jan; 27(1):32-40. PubMed ID: 2824570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report.
    Karlberg BE; Fyhrquist F; Grönhagen-Riska C; Tikkanen I; Ohman KP
    Scand J Urol Nephrol Suppl; 1984; 79():103-6. PubMed ID: 6089307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term monotherapy with lisinopril in renovascular hypertension.
    Fyhrquist F; Grönhagen-Riska C; Tikkanen I; Junggren IL
    J Cardiovasc Pharmacol; 1987; 9 Suppl 3():S61-5. PubMed ID: 2442555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enalapril in the treatment of renovascular hypertension.
    Knecht A; Grossman E; Rosenthal T
    Clin Exp Hypertens A; 1985; 7(10):1377-93. PubMed ID: 3000654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Labetalol in resistant hypertension.
    Hedstrand H
    Acta Med Scand Suppl; 1982; 665():125-8. PubMed ID: 6961758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiclinic comparison of labetalol to metoprolol in treatment of mild to moderate systemic hypertension.
    Frishman WH; Michelson EL; Johnson BF; Poland MP
    Am J Med; 1983 Oct; 75(4A):54-67. PubMed ID: 6356900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of effects of enalapril plus hydrochlorothiazide versus standard triple therapy on renal function in renovascular hypertension.
    Franklin SS; Smith RD
    Am J Med; 1985 Sep; 79(3C):14-23. PubMed ID: 2996342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enalapril (MK421) in the treatment of hypertension with renal artery stenosis.
    Hodsman GP; Brown JJ; Cumming AM; Davies DL; East BW; Lever AF; Morton JJ; Murray GD; Robertson JI
    J Hypertens Suppl; 1983 Oct; 1(1):109-17. PubMed ID: 6100599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-risk patients treated with enalapril maleate: safety considerations.
    Rucinska EJ; Small R; Irvin J
    Int J Cardiol; 1989 Feb; 22(2):249-59. PubMed ID: 2536644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.
    Todd PA; Heel RC
    Drugs; 1986 Mar; 31(3):198-248. PubMed ID: 3011386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M; Martell Claros N;
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.